Document Center Archive - Page 5 of 19 - Neurocrine Medical Affairs

Physiologic Glucocorticoid Dosing and Androstenedione Levels: Phase 3 CAHtalyst™ Study of CRENESSITY™ (Crinecerfont) in Adults

Physiologic Glucocorticoid Dosing and Androstenedione Levels: Phase 3 CAHtalyst™ Pediatric Study of CRENESSITY™ (Crinecerfont)

Long-Term Improvements with Valbenazine in Older and Elderly Patients With TD

Discontinuation of CRENESSITY™ (Crinecerfont)

Drug-Drug Interactions with CRENESSITY™ (Crinecerfont)

Definition of Physiologic Glucocorticoid Dose in the CAHtalyst™ Study

Definition of Physiologic Glucocorticoid Dose in the CAHtalyst™ Pediatric Study

Pregnancy and CRENESSITY™ (Crinecerfont)

Dosing and Administration of CRENESSITY™ (Crinecerfont)

Lactation and CRENESSITY™ (Crinecerfont)